))
Spiny Lobster Aquaculture for Pharma: Christophe Maier
Manage episode 355978453 series 3409854
Contenu fourni par Abigail Carroll. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Abigail Carroll ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
This week’s guest, Christophe Maier, Founder and CEO of Lagosta. Christophe was raised in Switzerland, on lake Geneva, but once he discovered the Mediterranean he couldn’t get enough of salty waterbodies!
Fast forward to adulthood and Christophe raises spiny lobsters, not for the European luxury food market as he originally expected, but for the pharma market which is turning out to be a very lucrative pivot. And he doesn’t even harm the lobsters. Instead, he up-cycles spiny lobster by-catch, grows them out in his onshore system and uses their “molts” or shedded shells to produce high-quality Chitosan.
Some of the subjects we will touch upon are:
- How Christophe came to Pivot
- How Climate change is affecting spiny lobsters and the Med in general
- How Christophe raises the spiny lobsters
- The particularities of the spiny lobster
- Traceability and spiny Lobster “fingerprints”
- The benefits of Chitosan
- Christophe’s growth plans and fundraise
- Christophe’s advice to entrepreneurs
Facebook
Instagram
Abigail Carroll LinkedIN
Happy Planet LinkedIN
Twitter
Listen on:
APPLE
YouTube
SPOTIFY
www.happyplanetpodcast.com
58 episodes
Partager
